GONZALO
DIAZ SOTO
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
ENRIQUE
ROMERO BOBILLO
Investigador en el periodo 1984-2017
Publicaciones en las que colabora con ENRIQUE ROMERO BOBILLO (11)
2016
-
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females
Journal of Human Nutrition and Dietetics, Vol. 29, Núm. 1, pp. 118-123
-
Impacto económico y satisfacción de la implantación de una consulta de alta resolución de patología nodular tiroidea en Endocrinología
Endocrinologia y Nutricion, Vol. 63, Núm. 8, pp. 414-420
-
Impacto económico y satisfacción de la implantación de una consulta de alta resolución de patología nodular tiroidea en Endocrinología
Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 8, pp. 414-420
-
Parathyroid Hormone Polymorphism RS6254 is Associated with the Development and Severity of Osteoporosis in Asymptomatic but not Normocalcemic Hyperthyroidism
Hormone and Metabolic Research, Vol. 48, Núm. 12, pp. 828-833
-
Trabecular bone score in patients with normocalcemic hyperparathyroidism
Endocrine Practice, Vol. 22, Núm. 6, pp. 703-707
2015
-
Clinical Expression of Calcium Sensing Receptor Polymorphism (A986S) in Normocalcemic and Asymptomatic Hyperparathyroidism
Hormone and Metabolic Research, Vol. 48, Núm. 3, pp. 163-168
-
Effects of a high-protein/low-carbohydrate versus a standard hypocaloric diet on weight and cardiovascular risk factors during 9 months: Role of a genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism)
Annals of Nutrition and Metabolism, Vol. 66, Núm. 2-3, pp. 125-131
-
Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor
Journal of Diabetes and its Complications, Vol. 29, Núm. 4, pp. 595-598
-
Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism
Endocrine
2014
-
Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: A prospective study
Diabetes Research and Clinical Practice, Vol. 104, Núm. 1, pp. 92-96
-
Role of genetic variation in the cannabinoid receptor gene (CNR1) (G1359A Polymorphism) on weight loss and cardiovascular risk factors after liraglutide treatment in obese patients with diabetes mellitus type 2
Journal of Investigative Medicine, Vol. 62, Núm. 2, pp. 324-327